Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis

Ann Rheum Dis. 2011 Feb;70(2):389-90. doi: 10.1136/ard.2009.127787. Epub 2010 May 6.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / physiopathology
  • Bone Density / drug effects*
  • Female
  • Hand Joints / physiopathology
  • Hip Joint / physiopathology
  • Humans
  • Infliximab
  • Lumbar Vertebrae / physiopathology
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab